Page last updated: 2024-08-21

thiazoles and Psychotic Disorders

thiazoles has been researched along with Psychotic Disorders in 162 studies

Research

Studies (162)

TimeframeStudies, this research(%)All Research%
pre-19909 (5.56)18.7374
1990's7 (4.32)18.2507
2000's86 (53.09)29.6817
2010's56 (34.57)24.3611
2020's4 (2.47)2.80

Authors

AuthorsStudies
Ayesa-Arriola, R; Crespo-Facorro, B; Gómez-Revuelta, M; Juncal-Ruiz, M; Pelayo-Terán, JM; Romero-Jiménez, R; Setién Suero, E; Suárez-Pinilla, P; Vázquez-Bourgon, J1
Correll, CU; DiPetrillo, L; Jiang, Y; Liu, Y; Pathak, S; Todtenkopf, MS1
Ayesa Arriola, R; Crespo Facorro, B; Gómez Revuelta, M; Ibáñez Alario, M; Juncal Ruiz, M; Mayoral-van Son, J; Ortiz-García de la Foz, V; Vázquez-Bourgon, J1
Alisauskiene, R; Gjestad, R; Johnsen, E; Jørgensen, HA; Kroken, RA; Løberg, EM1
Ensom, MHH; Johnson, EG; Johnson, HE; Wilby, KJ1
Crespo-Facorro, B; Gomez-Arnau, J; Juncal-Ruiz, M; Martinez-Garcia, O; Neergaard, KD; Ortiz-Garcia de la Foz, V; Ramirez-Bonilla, M; Suarez-Pinilla, P; Tabares-Seisdedos, R1
Crespo-Facorro, B; Díaz Martínez, Á; Ortiz-García de la Foz, V; Pérez-Iglesias, R; Suárez Pinilla, P; Vázquez-Bourgon, J1
Bateman, BT; Cohen, JM; Cohen, LS; Desai, RJ; Glynn, RJ; Hernandez-Diaz, S; Huybrechts, KF; Mogun, H; Park, Y; Patorno, E1
Crespo-Facorro, B; Gómez-Revuelta, M; González-Pinto, A; Juncal-Ruiz, M; Ortiz-García de la Foz, V; Pelayo-Terán, JM; Vázquez-Bourgon, J1
Cucchiaro, J; Hsu, J; Loebel, A; Nasrallah, HA; Phillips, D; Silva, R; Xu, J1
Citrome, L; Cucchiaro, J; Hernandez, D; Hsu, J; Loebel, A; McEvoy, JP; Pikalov, A1
Ayesa-Arriola, R; Crespo-Facorro, B; Mata, I; Ortiz-García de la Foz, V; Pérez-Iglesias, R; Suarez-Pinilla, P; Valdizan, EM; Vázquez-Barquero, JL1
Hong, JP; Kim, MS; Park, S; Yi, KK1
Ayesa-Arriola, R; Crespo-Facorro, B; de la Foz, VO; Martinez-Garcia, O; Mata, I; Pérez-Iglesias, R; Suarez-Pinilla, P; Valdizan, EM1
Bobes García, J; de la Gándara Martín, JJ; Gutiérrez Fraile, M1
Keator, DB; Kesler-West, ML; Mukherjee, J; Nguyen, DD; Potkin, SG; Preda, A; Shah, N; van Erp, TG1
Hugdahl, K; Johnsen, E; Jørgensen, HA; Kroken, RA; Løberg, EM; Sinkeviciute, I1
Bajpai, M; Banerjee, A; Gharat, LA; Gudi, GS; Gullapalli, S; Jadhav, S; Kadam, PA; Khairatkar-Joshi, N; Kumar, H; Merugu, RR; More, SV; Narayana, L; Pisal, DV; Raje, FA; Sangana, RR; Voleti, SR1
Aguglia, E; Bianchini, O; Cannavò, D; De Ronchi, D; Nespeca, C; Porcelli, S; Serretti, A; Trappoli, A1
Morrissette, DA; Stahl, SM1
Amado, JA; Ayesa-Arriola, R; Crespo-Facorro, B; Garcia-Unzueta, MT; Martínez García, O; Ortiz-Garcia de la Foz, V; Pérez-Iglesias, R; Suarez-Pinilla, P; Tabares-Seisdedos, R1
Calabrese, JR; Carta, MG; Moro, MF; Nardi, AE1
Connolly, JG; Schneeweiss, MC; Toomey, TJ1
Álamo, C; Bernardo, M; Bobes, J; Hidalgo, D; Murru, A; Saiz-Ruiz, J; Vieta, E1
Brugnoli, R; Carlino, N; D'Andreagiovanni, M; De Giorgi, R; Del Casale, A; Giardini, M; Girardi, P; Kotzalidis, GD; Rapinesi, C; Sacco, M1
Das, P1
Alonso-Martín, C; Arias-Loste, MT; Crespo, J; Crespo-Facorro, B; Fábrega, E; Martínez-García, O; Morlán-Coarasa, MJ; Ortiz-García de la Foz, V; Romero-Gómez, M1
Cross, ES; Davies, W; Guerrero, S; Humby, T; Messer, L1
Bai, YH; Cai, M; Chen, YC; Guo, L; McAlonan, GM; Tan, QR; Wang, HH; Wang, HN; Wang, Y; Wu, WJ; Zhang, RG; Zhang, YH; Zhang, ZJ1
Amado-Señaris, JA; Ayesa-Arriola, R; Correll, C; Crespo-Facorro, B; Labad, J; Ortiz-Garcia de la Foz, V; Pérez-Iglesias, R; Suarez-Pinilla, P; Teresa Garcia-Unzueta, M; Valdizan, EM1
Sikich, L1
Montejo, AL; Rico-Villademoros, F1
DelBello, MP; Ice, K; Keller, D; Miceli, J; Versavel, M1
Dietmaier, O; Gansmüller, R; Gründer, G; Hiemke, C; Leiblein, T; Vogel, F; Wassmuth, H1
Loebel, A; O'Gorman, CJ; Simpson, GM; Yang, R1
Alderman, JA; Gandelman, K; Glue, P; LaBadie, RR; Lombardo, I; Preskorn, SH; Versavel, M1
Díaz-Marsá, M; Rico-Villademoros, F; Sánchez, S1
Citrome, L; Glue, P; Karayal, ON; Yang, R1
Kumar, R; Sachdev, PS1
Ayesa, R; Crespo-Facorro, B; Martínez-Garcia, O; Mata, I; Pérez-Iglesias, R; Ramirez-Bonilla, M; Rodríguez-Sánchez, JM; Vázquez-Barquero, JL1
Akkaya, C; Alptekin, K; Brook, S; Danaci, AE; El Tallawy, H; Hafez, J; Karayal, ON; Lowe, W; Tzebelikos, E; Ucok, A1
Buitelaar, JK; Grootens, KP; Kahn, RS; Peuskens, J; Sabbe, BG; Thys, E; van Veelen, NM; Verkes, RJ1
Citrome, L; Jaffe, A; Levine, J2
Christodoulou, C; Douzenis, A; Gournellis, R; Lykouras, LP; Rizos, E1
Kaushik, S; Lindenmayer, JP; Maccabee, N1
Herman, BK; Lawson, WB; Lazariciu, I; Loebel, A; Malik, M1
DelBello, MP; Keller, D; Stewart, M; Versavel, M1
Anziano, R; Harrigan, RH; Miceli, JJ; O'Gorman, C; Shiovitz, T; Tensfeldt, TG1
Barth, KS; Garner, A; Phan, SV; Snarr, BS; VandenBerg, AM1
Johnsen, E; Jørgensen, HA; Kroken, RA; Wentzel-Larsen, T1
Anziano, RJ; Harrigan, RH; Miceli, JJ; O'Gorman, C; Shiovitz, T; Tensfeldt, TG1
Elsom, SJ; Gurvich, C; Kulkarni, J; McCauley-Elsom, K1
Lincoln, J; Preskorn, SH; Stewart, ME1
ASSAILLY, AA; DELAY, J1
Cucchiaro, J; Harvey, PD; Keefe, RS; Loebel, A; Ogasa, M1
Bobo, WV; Crystal, S; Gerhard, T; Huang, C; Lieberman, JA; Olfson, M1
Bachinsky, M; Cavus, I; Chappell, P; Glue, P; Karayal, ON; Kolluri, S; Stewart, M1
Dadić-Hero, E; Grahovac, T; Ružić, K; Sabljić, V; Sepić-Grahovac, D1
Baldaçara, L; Cordeiro, DC; Jackoswski, AP; Sanches, M1
Ayyanar, S; Kattimani, S; Menon, V1
Bitter, I; Czobor, P; Derks, EM; Fleischhacker, WW; Kahn, RS; Libiger, J; Volavka, J1
Johnsen, E; Jørgensen, HA; Kjelby, E; Kroken, RA; Løberg, EM1
Cucchiaro, J; Loebel, A; Ogasa, M; Potkin, SG1
Grant, JS; Keltner, NL; Moore, RL1
Jakovljevic, M; Mihaljevic-Peles, A; Muck-Seler, D; Mustapic, M; Nedic, G; Nikolac, M; Pivac, N; Sagud, M; Vuksan Cusa, B1
Létourneau, G; Moteshafi, H; Potvin, S; Stikarovska, I; Stip, E; Tourjman, V; Zhornitsky, S1
Johnsen, E; Jørgensen, HA; Kroken, RA; Løberg, EM1
Citrome, L; Hochfeld, M; Meng, X; Stahl, SM1
Dudova, I; Hrdlicka, M; Urbanek, T; Zedkova, I1
Bobo, WV; Chen, Y; Jayathilake, K; Meltzer, HY; Tang, T; Watts, K1
Li, YM; Ou, JJ; Wu, RR; Zhao, JP1
Chung, YC; Huang, GB; Kim, MG; Lee, KH; Park, TW; Yang, JC; Zhao, T1
Bitter, I; Bucci, P; Fleischhacker, WW; Galderisi, S; Kahn, RS; Libiger, J; Mucci, A1
Kolluri, S; Newcomer, JW; Pappadopulos, E1
Alvarez, E; Arranz, B; Corripio, I; Dueñas, R; Perez, V; Ramirez, N; Safont, G; San, L1
Adams, CE; Jones, H; Powney, MJ1
Akintola, M; Messerschmidt, C; Morewitz, J; Spiegel, DR1
Gunasekara, NS; Keating, GM; Spencer, CM2
Boeker, T1
McNeely, MJ; Yang, SH1
Daniel, DG1
Escalona, PR; Lu, BY; Lundgren, R; Roberts, BB1
Danileviciūte, V1
Kaye, NS2
BOUDIN, G; LAURAS, A; SALOMON, JC; SLIOSBERG, R1
de VERDIER, C; FINNSON, M; WERNER, I; WIMAN, LG1
GIACOBINI, E; IZIKOWITZ, S; NYGREN, S; SALUM, I1
SALUM, I1
BERGENER, M; FRITSCHKA, J1
SATTES, H1
BELLANDER-LOFVENBERG, S; LASSENIUS, B; OSTERMAN, E1
Harvey, PD; Romano, S; Siu, CO1
Daniel, DG; Romano, SJ; Simpson, G; Weiden, PJ1
Brieger, P1
Berardi, D; De Ronchi, D; Lorenzi, C; Serretti, A1
Lublin, HK1
Jaffe, R; Leavitt, R; Wind, T1
Kapur, S; Mamo, D; Mann, S; Papatheodorou, G; Remington, G; Shammi, CM; Therrien, F1
McDougle, CJ; Meighen, KG; Shelton, HM1
Davids, E; Gastpar, M; Hartwig, U1
Ravasia, S; Swensen, E1
Hasan, RA; Leibold, J; Patel, V1
Glick, ID; Romano, SJ; Simpson, GM; Siu, CO; Weiden, PJ1
Finkel, S1
Katz, IR1
Finzel, M; Fric, M; Laux, G1
Blair, J; Martin, A; Scahill, L; State, M1
Aguilar, Y; Alvarez, E; Carrió, I; Catafau, AM; Corripio, I; Mena, E; Perez, V; Puigdemont, D1
Addington, DE; Benattia, I; Dineen, M; Pantelis, C; Romano, SJ1
Staller, JA1
Korchounov, A; Oechsner, M1
Cole, SA; Jyringi, D; Sablosky, M; Saleem, R; Sedler, M; Shea, WP; Smith, A1
Murray, S; Pigott, T; Romano, SJ; Simpson, GM; Siu, CO; Weiden, P1
Lin, CL; Luu, SU; Mao, WC; Shiah, IS1
Baser, O; Engelhart, L; Finkel, S; Greenspan, A; Kozma, C; Long, S; Mahmoud, R1
Allen, MH; Battaglia, J; Citrome, L; Fishkind, A; Francis, A; Herr, DL; Hughes, D; Martel, M; Preval, H; Ross, R; Zimbroff, DL1
Mendhekar, DN1
Howland, RH1
Bond, LC; Borovicka, MC; Gaughan, KM1
Hwang, J; Kaufman, KR; Mohebati, A; Olsavsky, A; Stern, L1
Daniel, DG; Harvey, PD; Kilts, CD; Lieberman, JA; Nemeroff, CB; Newcomer, JW; Schatzberg, AF; Weiden, PJ1
Correll, CU1
Bowie, CR; Harvey, PD; Loebel, A1
Kostulski, A; Rabe-Jabłońska, J; Wyszogrodzka-Kucharska, A1
Adams, DH; Ascher-Svanum, H; Edwards, SB; Kinon, BJ; Lipkovich, I; Siris, SG1
Brook, S; Citrome, L; Czobor, P; Loebel, A; Mandel, FS; Volavka, J1
Chappell, P; Loebel, A; Miceli, J; Siu, C1
Alvarez, E; Barrachina, J; Campins, MJ; Madre, M; Pascual, JC; Pérez, V; Soler, J1
Barak, Y; Baruch, Y; Mazeh, D; Plopski, I1
Scott, LJ; Swainston Harrison, T1
Domin, S; Kasper, S; Kudla, D; Lambert, M; Naber, D1
De Oliveira, IR; Juruena, MF1
Duggal, HS1
Certa, K; Chism, LM; Mago, R; Pinninti, NR1
Allingham, B; Citrome, L; Jaffe, A; Levine, J; Martello, D1
Agid, O; Kapur, S; Loebel, A; Siu, C; Warrington, L1
Davidson, M; Levy, A; Weizer, M1
Goff, DC; Herz, L; Kletti, N; Ko, GN; Lapierre, K; Law, CG; Posever, T; Simmons, J; Wilner, KD1
Buffenstein, A; Feighner, J; Ferguson, J; Harrigan, EP; Jaffe, W; Keck, P; Morrissey, MR1
Kane, JM1
Daniel, DG; Harrigan, EP; Lakshminarayanan, M; Potkin, SG; Reeves, KR; Zimbroff, DL1
Allison, DB; Cappelleri, JC; Chandler, LP; Heo, M; Infante, MC; Mentore, JL; Weiden, PJ1
Bayle, FJ; Ghaoui, S; Olie, JP1
Bagnall, A; Kleijnen, J; Leitner, ML; Lewis, RA1
Bagnall, A; Leitner, ML; Lewis, RA1
Copeland, LF; Daniel, DG1
Harrigan, EP; Keck, PE; Reeves, KR1
Brook, S; Gunn, KP; Lucey, JV1
Harrigan, EP; Lesem, MD; Reeves, KR; Swift, RH; Zajecka, JM1
Cañas, F1
Casey, DE; Zorn, SH1
Daniel, DG; Harrigan, EP; Potkin, SG; Reeves, KR; Swift, RH1
Carnahan, RM; Lund, BC; Perry, PJ1
Fayek, M; Kingsbury, SJ; Simpson, GM; Trufasiu, D; Zada, J1
Green, B1
Goodnick, PJ1
Gutierrez, MA; Lee, V; Stimmel, GL1
Crismon, L; Dorson, PG; Patel, NC; Sierk, P1
Gastager, H1

Reviews

34 review(s) available for thiazoles and Psychotic Disorders

ArticleYear
Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
    The Annals of pharmacotherapy, 2017, Volume: 51, Issue:8

    Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Evidence-Based Medicine; Humans; Olanzapine; Parkinson Disease; Piperazines; Piperidines; Practice Guidelines as Topic; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Thiazoles; Urea

2017
Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy.
    CNS spectrums, 2014, Volume: 19, Issue:5

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain; Clozapine; Dibenzocycloheptenes; Drug Therapy, Combination; Heterocyclic Compounds, 4 or More Rings; Humans; Impulsive Behavior; Isoxazoles; Lurasidone Hydrochloride; Olanzapine; Paliperidone Palmitate; Piperazines; Piperidines; Polypharmacy; Psychotic Disorders; Quetiapine Fumarate; Receptors, Dopamine D2; Risperidone; Thiazoles; Violence

2014
Potential use of lurasidone for the treatment of bipolar psychosis.
    Expert opinion on investigational drugs, 2015, Volume: 24, Issue:4

    Topics: Animals; Antipsychotic Agents; Bipolar Disorder; Humans; Isoindoles; Lurasidone Hydrochloride; Psychotic Disorders; Schizophrenia; Thiazoles

2015
Antipsychotic switching in schizoaffective disorder: A systematic review.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2016, Volume: 17, Issue:7

    Topics: Antipsychotic Agents; Aripiprazole; Drug Substitution; Humans; Piperazines; Psychotic Disorders; Randomized Controlled Trials as Topic; Risperidone; Thiazoles

2016
Efficacy of atypical antipsychotics in early-onset schizophrenia and other psychotic disorders.
    The Journal of clinical psychiatry, 2008, Volume: 69 Suppl 4

    Topics: Adolescent; Adult; Age of Onset; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Brain Diseases; Child; Chronic Disease; Clozapine; Comorbidity; Disease Progression; Humans; Magnetic Resonance Imaging; Olanzapine; Piperazines; Prognosis; Psychotic Disorders; Quinolones; Schizophrenia; Thiazoles; Treatment Failure

2008
Akathisia and second-generation antipsychotic drugs.
    Current opinion in psychiatry, 2009, Volume: 22, Issue:3

    Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Isoxazoles; Olanzapine; Piperazines; Piperidines; Prevalence; Psychomotor Agitation; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risk Factors; Risperidone; Sulpiride; Thiazoles

2009
Antipsychotics in pregnancy.
    Journal of psychiatric and mental health nursing, 2010, Volume: 17, Issue:2

    Topics: Abnormalities, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes, Gestational; Dibenzothiazepines; Female; Humans; Infant, Newborn; Olanzapine; Piperazines; Pregnancy; Pregnancy Complications; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles

2010
Ziprasidone for psychotic disorders: a meta-analysis and systematic review of the relationship between pharmacokinetics, pharmacodynamics, and clinical profile.
    Clinical therapeutics, 2011, Volume: 33, Issue:12

    Topics: Antipsychotic Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Evidence-Based Medicine; Food-Drug Interactions; Humans; Patient Selection; Piperazines; Psychotic Disorders; Receptors, Dopamine D2; Risk Assessment; Thiazoles; Treatment Outcome

2011
Changes in weight, plasma lipids, and glucose in adults treated with ziprasidone: a comprehensive analysis of pfizer-initiated clinical trials.
    The Journal of clinical psychiatry, 2012, Volume: 73, Issue:6

    Topics: Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Body Mass Index; Body Weight; Clinical Trials as Topic; Drug Industry; Fasting; Humans; Lipids; Piperazines; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Time Factors

2012
Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation).
    The Cochrane database of systematic reviews, 2012, Nov-14, Volume: 11

    Topics: Aggression; Antipsychotic Agents; Aripiprazole; Clopenthixol; Dystonia; Haloperidol; Humans; Lorazepam; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Randomized Controlled Trials as Topic; Sleep; Thiazoles

2012
Spotlight on ziprasidone in schizophrenia and schizoaffective disorder.
    CNS drugs, 2002, Volume: 16, Issue:9

    Topics: Antipsychotic Agents; Humans; Piperazines; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Treatment Outcome

2002
Recent developments in pharmacotherapy for the acutely psychotic patient.
    Journal of emergency nursing, 2002, Volume: 28, Issue:6 Suppl

    Topics: Anti-Dyskinesia Agents; Antipsychotic Agents; Benzodiazepines; Haloperidol; Humans; Injections, Intramuscular; Olanzapine; Piperazines; Pirenzepine; Psychomotor Agitation; Psychotic Disorders; Thiazoles

2002
[Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
    Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:11

    Topics: Adolescent; Amisulpride; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Carbamazepine; Child; Diagnosis, Differential; Dibenzothiazepines; Dogs; Female; Humans; Imidazoles; Indoles; Lithium Carbonate; Male; Mianserin; Middle Aged; Mirtazapine; Olanzapine; Piperazines; Pirenzepine; Placebos; Prognosis; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Thiazoles; Time Factors

2002
New antipsychotics and schizophrenia: a review on efficacy and side effects.
    Current medicinal chemistry, 2004, Volume: 11, Issue:3

    Topics: Antipsychotic Agents; Benzodiazepines; Clinical Trials as Topic; Cognition; Dibenzothiazepines; Drug Interactions; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome

2004
[Ziprasidone. A new second-generation antipsychotic agent].
    Ugeskrift for laeger, 2004, Mar-29, Volume: 166, Issue:14

    Topics: Administration, Oral; Antipsychotic Agents; Dopamine Antagonists; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Schizophrenia; Serotonin Antagonists; Thiazoles

2004
Pharmacology of antipsychotics in the elderly: a focus on atypicals.
    Journal of the American Geriatrics Society, 2004, Volume: 52, Issue:12 Suppl

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Serotonin Antagonists; Thiazoles; Treatment Outcome; United States

2004
Optimizing atypical antipsychotic treatment strategies in the elderly.
    Journal of the American Geriatrics Society, 2004, Volume: 52, Issue:12 Suppl

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dementia; Dibenzothiazepines; Humans; Olanzapine; Parkinson Disease; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome

2004
Best clinical practice with ziprasidone IM: update after 2 years of experience.
    CNS spectrums, 2005, Volume: 10, Issue:9

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Critical Care; Emergency Medical Services; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychomotor Agitation; Psychotic Disorders; Severity of Illness Index; Thiazoles

2005
[Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
    Przeglad lekarski, 2005, Volume: 62, Issue:9

    Topics: Antipsychotic Agents; Body Weight; Clozapine; Dibenzothiazepines; Humans; Hyperlipidemias; Leptin; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles; Weight Gain

2005
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.
    CNS drugs, 2006, Volume: 20, Issue:12

    Topics: Antipsychotic Agents; Area Under Curve; Humans; Injections, Intramuscular; Long QT Syndrome; Piperazines; Psychotic Disorders; Schizophrenia; Tablets; Thiazoles; Treatment Outcome

2006
Treatment of psychosis: 30 years of progress.
    Journal of clinical pharmacy and therapeutics, 2006, Volume: 31, Issue:6

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Receptors, Dopamine; Receptors, Serotonin; Risperidone; Schizophrenia; Thiazoles

2006
[New antipsychotic drugs].
    Harefuah, 1997, Volume: 133, Issue:1-2

    Topics: Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Clinical Trials as Topic; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Pramipexole; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles

1997
Tardive dyskinesia in affective disorders.
    The Journal of clinical psychiatry, 1999, Volume: 60 Suppl 5

    Topics: Adult; Affective Disorders, Psychotic; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Carbamazepine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Humans; Imidazoles; Indoles; Male; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risk Assessment; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome

1999
Antipsychotic-induced weight gain: a comprehensive research synthesis.
    The American journal of psychiatry, 1999, Volume: 156, Issue:11

    Topics: Antipsychotic Agents; Clinical Trials as Topic; Clozapine; Confidence Intervals; Drug Administration Schedule; Humans; Molindone; Piperazines; Placebos; Psychotic Disorders; Research Design; Thiazoles; Treatment Outcome; Weight Gain

1999
[New antipsychotic agents].
    L'Encephale, 1999, Volume: 25 Spec No 3

    Topics: Amisulpride; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Humans; Imidazoles; Indoles; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Sulpiride; Thiazoles

1999
Ziprasidone for schizophrenia and severe mental illness.
    The Cochrane database of systematic reviews, 2000, Issue:2

    Topics: Antipsychotic Agents; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles

2000
Ziprasidone for schizophrenia and severe mental illness.
    The Cochrane database of systematic reviews, 2000, Issue:4

    Topics: Antipsychotic Agents; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles

2000
Ziprasidone: comprehensive overview and clinical use of a novel antipsychotic.
    Expert opinion on investigational drugs, 2000, Volume: 9, Issue:4

    Topics: Animals; Antipsychotic Agents; Clinical Trials as Topic; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Thiazoles

2000
The pharmacology of weight gain with antipsychotics.
    The Journal of clinical psychiatry, 2001, Volume: 62 Suppl 7

    Topics: Animals; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Eating; Humans; Olanzapine; Piperazines; Pirenzepine; Psychotic Disorders; Quetiapine Fumarate; Rats; Receptors, Neurotransmitter; Schizophrenia; Thiazoles; Weight Gain

2001
Ziprasidone, a new atypical antipsychotic drug.
    Pharmacotherapy, 2001, Volume: 21, Issue:6

    Topics: Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Drug Interactions; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Tourette Syndrome

2001
Focus on ziprasidone.
    Current medical research and opinion, 2001, Volume: 17, Issue:2

    Topics: Antipsychotic Agents; Clinical Trials as Topic; Dopamine Antagonists; Humans; Piperazines; Psychotic Disorders; Schizophrenia; Serotonin Antagonists; Thiazoles; Treatment Outcome

2001
Ziprasidone: profile on safety.
    Expert opinion on pharmacotherapy, 2001, Volume: 2, Issue:10

    Topics: Antipsychotic Agents; Blood Glucose; Electrocardiography; Humans; Lipids; Piperazines; Prolactin; Psychotic Disorders; Thiazoles; Weight Gain

2001
Ziprasidone: an atypical antipsychotic drug for the treatment of schizophrenia.
    Clinical therapeutics, 2002, Volume: 24, Issue:1

    Topics: Administration, Oral; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Drug Interactions; Drug Overdose; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Tourette Syndrome

2002
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder.
    Drugs, 2002, Volume: 62, Issue:8

    Topics: Administration, Oral; Antipsychotic Agents; Clinical Trials as Topic; Drug Interactions; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome

2002

Trials

69 trial(s) available for thiazoles and Psychotic Disorders

ArticleYear
Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone.
    The international journal of neuropsychopharmacology, 2020, 04-23, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Antipsychotic Agents; Aripiprazole; Female; Follow-Up Studies; Haloperidol; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Young Adult

2020
Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study.
    The Journal of clinical psychiatry, 2020, 03-17, Volume: 81, Issue:2

    Topics: Adult; Alcoholism; Antipsychotic Agents; Comorbidity; Female; Hospitalization; Humans; Male; Olanzapine; Outcome Assessment, Health Care; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Severity of Illness Index; Symptom Flare Up; Thiazoles; Time Factors

2020
A 3-year prospective study on the metabolic effect of aripiprazole, quetiapine and ziprasidone: A pragmatic clinical trial in first episode psychosis patients.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2020, Volume: 39

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Energy Metabolism; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Time Factors; Weight Gain; Young Adult

2020
Incidence and risk factors of acute akathisia in 493 individuals with first episode non-affective psychosis: a 6-week randomised study of antipsychotic treatment.
    Psychopharmacology, 2017, Volume: 234, Issue:17

    Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Female; Haloperidol; Humans; Incidence; Male; Olanzapine; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Schizophrenia; Thiazoles; Young Adult

2017
Long-term metabolic effects of aripiprazole, ziprasidone and quetiapine: a pragmatic clinical trial in drug-naïve patients with a first-episode of non-affective psychosis.
    Psychopharmacology, 2018, Volume: 235, Issue:1

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Thiazoles; Triglycerides; Young Adult

2018
Long-Term Antipsychotic Effectiveness in First Episode of Psychosis: A 3-Year Follow-Up Randomized Clinical Trial Comparing Aripiprazole, Quetiapine, and Ziprasidone.
    The international journal of neuropsychopharmacology, 2018, 12-01, Volume: 21, Issue:12

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Follow-Up Studies; Humans; Male; Outcome Assessment, Health Care; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Young Adult

2018
Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study.
    Journal of psychiatric research, 2013, Volume: 47, Issue:5

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Basal Ganglia Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; International Cooperation; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult

2013
Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.
    The Journal of clinical psychiatry, 2013, Volume: 74, Issue:2

    Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Olanzapine; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Time Factors; Treatment Failure; Treatment Outcome

2013
Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: a 12-week randomized, flexible-dose, open-label trial.
    Schizophrenia research, 2013, Volume: 147, Issue:2-3

    Topics: Adult; Analysis of Variance; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Humans; Male; Outcome Assessment, Health Care; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Retrospective Studies; Thiazoles; Time Factors; Young Adult

2013
Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study.
    Behavioral and brain functions : BBF, 2013, Jul-19, Volume: 9

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Appetite; Benzodiazepines; Body Composition; Body Weight; Cholesterol, HDL; Cholesterol, LDL; Energy Metabolism; Female; Humans; Male; Middle Aged; Olanzapine; Pilot Projects; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Weight Gain; Young Adult

2013
Treatment of first-episode non-affective psychosis: a randomized comparison of aripiprazole, quetiapine and ziprasidone over 1 year.
    Psychopharmacology, 2014, Volume: 231, Issue:2

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Dibenzothiazepines; Female; Humans; Male; Patient Dropouts; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Thiazoles; Treatment Outcome; Young Adult

2014
D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder.
    CNS spectrums, 2014, Volume: 19, Issue:2

    Topics: Adult; Algorithms; Antipsychotic Agents; Benzamides; Brain; Dose-Response Relationship, Drug; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Positron-Emission Tomography; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrrolidines; Receptors, Dopamine D2; Schizophrenia; Statistics as Topic; Thiazoles; Young Adult

2014
Hallucinations in acutely admitted patients with psychosis, and effectiveness of risperidone, olanzapine, quetiapine, and ziprasidone: a pragmatic, randomized study.
    BMC psychiatry, 2013, Sep-30, Volume: 13

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Hallucinations; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome

2013
Comparison of metabolic effects of aripiprazole, quetiapine and ziprasidone after 12 weeks of treatment in first treated episode of psychosis.
    Schizophrenia research, 2014, Volume: 159, Issue:1

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Cholesterol; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Male; Piperazines; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Sex Factors; Thiazoles; Weight Gain

2014
Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study.
    Psychopharmacology, 2016, Volume: 233, Issue:23-24

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Female; Humans; Incidence; Male; Metabolic Diseases; Middle Aged; Non-alcoholic Fatty Liver Disease; Piperazines; Prospective Studies; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Young Adult

2016
An assessor-blinded, randomized comparison of efficacy and tolerability of switching from olanzapine to ziprasidone and the combination of both in schizophrenia spectrum disorders.
    Journal of psychiatric research, 2017, Volume: 85

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Benzodiazepines; Drug Substitution; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Metabolic Syndrome; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Single-Blind Method; Thiazoles; Treatment Outcome; Weight Gain

2017
Effects of aripiprazole, quetiapine and ziprasidone on plasma prolactin levels in individuals with first episode nonaffective psychosis: Analysis of a randomized open-label 1year study.
    Schizophrenia research, 2017, Volume: 189

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Brief Psychiatric Rating Scale; Cohort Studies; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Piperazines; Prolactin; Psychotic Disorders; Quetiapine Fumarate; Sex Characteristics; Thiazoles; Time Factors; Young Adult

2017
Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.
    Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:5

    Topics: Adolescent; Adult; Antipsychotic Agents; Female; Humans; Male; Piperazines; Prospective Studies; Psychotic Disorders; Schizophrenia; Sexual Dysfunction, Physiological; Thiazoles

2008
Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder.
    Journal of child and adolescent psychopharmacology, 2008, Volume: 18, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Male; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Severity of Illness Index; Thiazoles

2008
Long-term improvement in efficacy and safety after switching to ziprasidone in stable outpatients with schizophrenia.
    CNS spectrums, 2008, Volume: 13, Issue:10

    Topics: Adolescent; Adult; Ambulatory Care; Antipsychotic Agents; Female; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult

2008
The impact of calories and fat content of meals on oral ziprasidone absorption: a randomized, open-label, crossover trial.
    The Journal of clinical psychiatry, 2009, Volume: 70, Issue:1

    Topics: Adult; Antipsychotic Agents; Biological Availability; Bipolar Disorder; Cross-Over Studies; Dietary Fats; Drug Administration Schedule; Energy Intake; Female; Food-Drug Interactions; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Young Adult

2009
Effectiveness and tolerability of oral ziprasidone in psychiatric inpatients with an acute exacerbation of schizophrenia or schizoaffective disorder: a multicenter, prospective, and naturalistic study.
    The Journal of clinical psychiatry, 2009, Volume: 70, Issue:4

    Topics: Acute Disease; Adult; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Administration Schedule; Female; Hospitalization; Humans; In Vitro Techniques; Length of Stay; Piperazines; Prospective Studies; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome

2009
Effect of ziprasidone dose on all-cause discontinuation rates in acute schizophrenia and schizoaffective disorder: a post-hoc analysis of 4 fixed-dose randomized clinical trials.
    Schizophrenia research, 2009, Volume: 111, Issue:1-3

    Topics: Acute Disease; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Piperazines; Proportional Hazards Models; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome

2009
Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
    The Journal of clinical psychiatry, 2009, Apr-21, Volume: 70, Issue:5

    Topics: Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Cognition Disorders; Female; Follow-Up Studies; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Perphenazine; Piperazines; Prospective Studies; Psychotic Disorders; Risperidone; Severity of Illness Index; Sulpiride; Thiazoles

2009
Efficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
    International clinical psychopharmacology, 2009, Volume: 24, Issue:5

    Topics: Adult; Aged; Antipsychotic Agents; Benzodiazepines; Drug Administration Schedule; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles

2009
Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial.
    Schizophrenia bulletin, 2011, Volume: 37, Issue:2

    Topics: Adult; Alanine Transaminase; Antipsychotic Agents; Aspartate Aminotransferases; Basal Ganglia Diseases; Benzodiazepines; Biperiden; Blood Glucose; Body Weight; Cholesterol; Chronic Disease; Electrocardiography; Female; Humans; Male; Muscarinic Antagonists; Olanzapine; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychometrics; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Triglycerides; Young Adult

2011
Ziprasidone in Black patients with schizophrenia: analysis of four short-term, double-blind studies.
    CNS spectrums, 2009, Volume: 14, Issue:9

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Black People; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult

2009
Psychosocial functioning and health-related quality of life in children and adolescents treated with open-label ziprasidone for bipolar mania, schizophrenia, or schizoaffective disorder.
    Journal of child and adolescent psychopharmacology, 2009, Volume: 19, Issue:6

    Topics: Adolescent; Antipsychotic Agents; Bipolar Disorder; Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Health Status; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quality of Life; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Social Behavior; Thiazoles; Treatment Outcome

2009
Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.
    Pharmacotherapy, 2010, Volume: 30, Issue:2

    Topics: Administration, Oral; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Electrocardiography; Female; Haloperidol; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles

2010
Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone.
    BMC psychiatry, 2010, Mar-24, Volume: 10

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Galactorrhea; Hospitalization; Humans; Length of Stay; Male; Olanzapine; Patient Readmission; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Severity of Illness Index; Thiazoles; Treatment Outcome

2010
Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
    Clinical therapeutics, 2010, Volume: 32, Issue:3

    Topics: Adult; Aged; Antipsychotic Agents; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Female; Haloperidol; Heart Rate; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Single-Blind Method; Thiazoles; Young Adult

2010
Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone.
    Schizophrenia research, 2011, Volume: 127, Issue:1-3

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Cognition Disorders; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Interview, Psychological; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Young Adult

2011
Switching from quetiapine to ziprasidone: a sixteen-week, open-label, multicenter study evaluating the effectiveness and safety of ziprasidone in outpatient subjects with schizophrenia or schizoaffective disorder.
    Journal of psychiatric practice, 2011, Volume: 17, Issue:2

    Topics: Adolescent; Adult; Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Cognition; Dibenzothiazepines; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Treatment Outcome; Triglycerides; Young Adult

2011
Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone.
    Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2011, Volume: 33, Issue:1

    Topics: Adult; Aggression; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Emergency Services, Psychiatric; Female; Haloperidol; Humans; Hypnotics and Sedatives; Injections, Intramuscular; Male; Midazolam; Olanzapine; Piperazines; Promethazine; Psychomotor Agitation; Psychotic Disorders; Thiazoles; Tranquilizing Agents

2011
Efficacy of antipsychotic drugs against hostility in the European First-Episode Schizophrenia Trial (EUFEST).
    The Journal of clinical psychiatry, 2011, Volume: 72, Issue:7

    Topics: Adult; Aggression; Amisulpride; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Haloperidol; Hostility; Humans; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles; Treatment Outcome

2011
Anti-depressive effectiveness of olanzapine, quetiapine, risperidone and ziprasidone: a pragmatic, randomized trial.
    BMC psychiatry, 2011, Aug-31, Volume: 11

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Benzodiazepines; Depression; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles

2011
Double-blind comparison of the safety and efficacy of lurasidone and ziprasidone in clinically stable outpatients with schizophrenia or schizoaffective disorder.
    Schizophrenia research, 2011, Volume: 132, Issue:2-3

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Body Weight; Cholesterol; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Isoindoles; Lurasidone Hydrochloride; Male; Middle Aged; Outpatients; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Time Factors; Treatment Outcome; Triglycerides; Young Adult

2011
The lack of effect of ziprasidone on platelet serotonin concentration in schizophrenic patients.
    Psychopharmacology, 2012, Volume: 219, Issue:4

    Topics: Antipsychotic Agents; Blood Platelets; Dose-Response Relationship, Drug; Female; Humans; Male; Piperazines; Psychotic Disorders; Schizophrenia; Serotonin; Serotonin Antagonists; Thiazoles; Time Factors

2012
Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: a pragmatic, randomized trial.
    European psychiatry : the journal of the Association of European Psychiatrists, 2013, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Benzodiazepines; Cognition; Dibenzothiazepines; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Thiazoles; Treatment Outcome; Young Adult

2013
Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
    Human psychopharmacology, 2012, Volume: 27, Issue:1

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Labeling; Female; Haloperidol; Humans; Isoxazoles; Male; Middle Aged; Piperazines; Piperidines; Prospective Studies; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult

2012
Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.
    Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:9

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Atherosclerosis; Bipolar Disorder; Cohort Studies; Diagnostic and Statistical Manual of Mental Disorders; Drug Monitoring; Dyslipidemias; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; North America; Patient Dropouts; Piperazines; Psychotic Disorders; Quinolones; Risk Factors; Schizophrenia; Severity of Illness Index; Thiazoles; Weight Loss

2012
Efficacy and tolerability of ziprasidone vs. olanzapine in naive first-episode schizophrenia: a 6-week, randomized, open-label, flexible-dose study.
    Pharmacopsychiatry, 2012, Volume: 45, Issue:5

    Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Comparative Effectiveness Research; Dose-Response Relationship, Drug; Drug Monitoring; Episode of Care; Female; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Time Factors; Treatment Outcome; Weight Gain

2012
Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
    International clinical psychopharmacology, 2012, Volume: 27, Issue:4

    Topics: Adolescent; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Body Weight; Female; Humans; Lipids; Male; Middle Aged; Patient Dropouts; Piperazines; Prolactin; Psychiatric Status Rating Scales; Psychotic Disorders; Thiazoles

2012
Persistent negative symptoms in first episode patients with schizophrenia: results from the European First Episode Schizophrenia Trial.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2013, Volume: 23, Issue:3

    Topics: Adolescent; Adult; Amisulpride; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Neuropsychological Tests; Olanzapine; Piperazines; Psychomotor Disorders; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology; Sulpiride; Thiazoles; Treatment Outcome; Young Adult

2013
One-year, randomized, open trial comparing olanzapine, quetiapine, risperidone and ziprasidone effectiveness in antipsychotic-naive patients with a first-episode psychosis.
    Psychiatry research, 2012, Dec-30, Volume: 200, Issue:2-3

    Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Dibenzothiazepines; Female; Humans; Male; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome

2012
Ziprasidone augmentation of clozapine in 11 patients.
    The Journal of clinical psychiatry, 2003, Volume: 64, Issue:2

    Topics: Adult; Antipsychotic Agents; Clozapine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome; Weight Gain

2003
Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    Psychopharmacology, 2004, Volume: 172, Issue:3

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition; Double-Blind Method; Female; Hospitalization; Humans; Male; Memory; Middle Aged; Olanzapine; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles

2004
Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone.
    Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:6

    Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Body Weight; Female; Health Status Indicators; Humans; Male; Middle Aged; Olanzapine; Piperazines; Prolactin; Psychotic Disorders; Risperidone; Schizophrenia; Thiazoles; Withholding Treatment

2003
A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.
    The American journal of psychiatry, 2004, Volume: 161, Issue:5

    Topics: Adult; Antipsychotic Agents; Brain; Corpus Striatum; Drug Administration Schedule; Female; Humans; Male; Piperazines; Psychotic Disorders; Pyrimidinones; Raclopride; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT2; Schizophrenia; Thiazoles; Tomography, Emission-Computed

2004
Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
    The American journal of psychiatry, 2004, Volume: 161, Issue:10

    Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome; Weight Gain

2004
[QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
    Psychiatrische Praxis, 2004, Volume: 31 Suppl 1

    Topics: Antipsychotic Agents; Electrocardiography; Germany; Hospitalization; Hospitals, Psychiatric; Humans; Long QT Syndrome; Piperazines; Prospective Studies; Psychotic Disorders; Risk Assessment; Thiazoles; Torsades de Pointes

2004
Electrocardiographic changes in children and adolescents treated with ziprasidone: a prospective study.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2005, Volume: 44, Issue:1

    Topics: Adolescent; Antipsychotic Agents; Child; Child Development Disorders, Pervasive; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Obsessive-Compulsive Disorder; Piperazines; Prospective Studies; Psychotic Disorders; Thiazoles; Tourette Syndrome

2005
Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
    Progress in neuro-psychopharmacology & biological psychiatry, 2005, Volume: 29, Issue:1

    Topics: Adult; Antipsychotic Agents; Benzamides; Drug Resistance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Neostriatum; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Single-Blind Method; Thiazoles; Tomography, Emission-Computed, Single-Photon; Treatment Failure

2005
Efficacy and tolerability of ziprasidone versus risperidone in patients with acute exacerbation of schizophrenia or schizoaffective disorder: an 8-week, double-blind, multicenter trial.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:12

    Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Hyperprolactinemia; Male; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Risperidone; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sexual Dysfunctions, Psychological; Sleep Initiation and Maintenance Disorders; Thiazoles; Treatment Outcome

2004
Parenteral ziprasidone: a new atypical neuroleptic for emergency treatment of psychosis in Parkinson's disease?
    Human psychopharmacology, 2005, Volume: 20, Issue:3

    Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Electrocardiography; Emergency Medical Services; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Parkinson Disease; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Thiazoles

2005
Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia.
    The American journal of psychiatry, 2005, Volume: 162, Issue:8

    Topics: Ambulatory Care; Antipsychotic Agents; Benzodiazepines; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Administration Schedule; Follow-Up Studies; Humans; Obesity; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome; Weight Gain

2005
Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine.
    The Journal of neuropsychiatry and clinical neurosciences, 2006,Winter, Volume: 18, Issue:1

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Olanzapine; Patient Admission; Piperazines; Psychometrics; Psychotic Disorders; Schizophrenia; Thiazoles

2006
A 24-week randomized study of olanzapine versus ziprasidone in the treatment of schizophrenia or schizoaffective disorder in patients with prominent depressive symptoms.
    Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:2

    Topics: Antipsychotic Agents; Benzodiazepines; Depression; Glycated Hemoglobin; Humans; Olanzapine; Patient Dropouts; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Triglycerides; United States; Weight Gain

2006
Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antipsychotic Agents; Female; Haloperidol; Hospitalization; Hostility; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome

2006
Intramuscular ziprasidone treatment of acute psychotic agitation in elderly patients with schizophrenia.
    The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2006, Volume: 14, Issue:7

    Topics: Acute Disease; Aged; Aged, 80 and over; Antipsychotic Agents; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Thiazoles

2006
Early onset of antipsychotic response in the treatment of acutely agitated patients with psychotic disorders.
    Schizophrenia research, 2008, Volume: 102, Issue:1-3

    Topics: Acute Disease; Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hospitalization; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Thiazoles; Time Factors; Treatment Outcome

2008
An exploratory haloperidol-controlled dose-finding study of ziprasidone in hospitalized patients with schizophrenia or schizoaffective disorder.
    Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:4

    Topics: Adult; Antipsychotic Agents; Dose-Response Relationship, Drug; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Hospitalization; Humans; Male; Middle Aged; Neurologic Examination; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome

1998
Ziprasidone 40 and 120 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 4-week placebo-controlled trial.
    Psychopharmacology, 1998, Volume: 140, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles

1998
Ziprasidone 80 mg/day and 160 mg/day in the acute exacerbation of schizophrenia and schizoaffective disorder: a 6-week placebo-controlled trial. Ziprasidone Study Group.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1999, Volume: 20, Issue:5

    Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Thiazoles

1999
Ziprasidone in the short-term treatment of patients with schizoaffective disorder: results from two double- blind, placebo-controlled, multicenter studies.
    Journal of clinical psychopharmacology, 2001, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Antipsychotic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Movement Disorders; Piperazines; Psychotic Disorders; Thiazoles; Treatment Outcome

2001
Intramuscular ziprasidone compared with intramuscular haloperidol in the treatment of acute psychosis. Ziprasidone I.M. Study Group.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:12

    Topics: Acute Disease; Adult; Aged; Antipsychotic Agents; Brief Psychiatric Rating Scale; Drug Administration Schedule; Female; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Psychotic Disorders; Severity of Illness Index; Thiazoles; Treatment Outcome

2000
Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:1

    Topics: Antipsychotic Agents; Area Under Curve; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Thiazoles; Treatment Outcome

2001
Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial.
    Psychopharmacology, 2001, Volume: 155, Issue:2

    Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Double-Blind Method; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Thiazoles

2001
The apparent effects of ziprasidone on plasma lipids and glucose.
    The Journal of clinical psychiatry, 2001, Volume: 62, Issue:5

    Topics: Adult; Analysis of Variance; Antipsychotic Agents; Blood Glucose; Body Mass Index; Body Weight; Cholesterol; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lipids; Male; Outcome Assessment, Health Care; Piperazines; Psychotic Disorders; Schizophrenia; Thiazoles; Triglycerides

2001

Other Studies

59 other study(ies) available for thiazoles and Psychotic Disorders

ArticleYear
The Influence of Substance Use on Side Effects of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Psychosis.
    Substance use & misuse, 2021, Volume: 56, Issue:12

    Topics: Adult; Benzodiazepines; Female; Humans; Male; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Substance-Related Disorders; Thiazoles

2021
Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.
    The American journal of psychiatry, 2018, 06-01, Volume: 175, Issue:6

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Diabetes, Gestational; Female; Humans; Olanzapine; Piperazines; Pregnancy; Pregnancy Complications; Psychotic Disorders; Quetiapine Fumarate; Risk Factors; Risperidone; Thiazoles; Young Adult

2018
Switching to ziprasidone in the clinical practice setting: an open-label study.
    International journal of psychiatry in medicine, 2013, Volume: 45, Issue:2

    Topics: Adult; Antipsychotic Agents; Body Weight; Brief Psychiatric Rating Scale; Drug Substitution; Female; Follow-Up Studies; Humans; Male; Middle Aged; Piperazines; Psychometrics; Psychotic Disorders; Quality of Life; Schizophrenia; Schizophrenic Psychology; Thiazoles; Treatment Outcome

2013
Discovery of benzo[d]imidazo[5,1-b]thiazole as a new class of phosphodiesterase 10A inhibitors.
    Bioorganic & medicinal chemistry letters, 2013, Dec-15, Volume: 23, Issue:24

    Topics: Animals; Antipsychotic Agents; Disease Models, Animal; Dizocilpine Maleate; Drug Evaluation, Preclinical; Enzyme Activation; Female; Half-Life; Imidazoles; Molecular Docking Simulation; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Psychotic Disorders; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiazoles

2013
Effects of antipsychotic drugs on insight in schizophrenia.
    Psychiatry research, 2014, Aug-15, Volume: 218, Issue:1-2

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Awareness; Benzodiazepines; Female; Haloperidol; Humans; Male; Middle Aged; Olanzapine; Piperazines; Psychotic Disorders; Quinolones; Schizophrenia; Schizophrenic Psychology; Thiazoles

2014
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011.
    Psychiatric services (Washington, D.C.), 2015, Volume: 66, Issue:6

    Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles

2015
Effectiveness of switching from oral ziprasidone to risperidone in a patient with comorbid autistic disorder, profound intellectual disability, Gilbert syndrome, and exacerbation of psychosis.
    Psychiatria Danubina, 2016, Volume: 28, Issue:1

    Topics: Adult; Antipsychotic Agents; Autistic Disorder; Comorbidity; Gilbert Disease; Humans; Intellectual Disability; Male; Piperazines; Psychotic Disorders; Risperidone; Thiazoles

2016
A Case of Sleepwalking With Sleep-Related Eating Associated With Ziprasidone Therapy in a Patient With Schizoaffective Disorder.
    Journal of clinical psychopharmacology, 2016, Volume: 36, Issue:4

    Topics: Adult; Antipsychotic Agents; Feeding and Eating Disorders; Humans; Male; Parasomnias; Piperazines; Psychotic Disorders; Somnambulism; Thiazoles

2016
A pharmacological mouse model suggests a novel risk pathway for postpartum psychosis.
    Psychoneuroendocrinology, 2016, Volume: 74

    Topics: Animals; Antipsychotic Agents; Behavior, Animal; Coumarins; Disease Models, Animal; Female; Gene Expression; Mice; Mice, Inbred C57BL; Piperazines; Psychotic Disorders; Puerperal Disorders; Steryl-Sulfatase; Sulfonamides; Thiazoles

2016
The use of ziprasidone in clinical practice: analysis of pharmacokinetic and pharmacodynamic aspects from data of a drug monitoring survey.
    European psychiatry : the journal of the Association of European Psychiatrists, 2009, Volume: 24, Issue:3

    Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Male; Mood Disorders; Piperazines; Psychotic Disorders; Retrospective Studies; Severity of Illness Index; Thiazoles; Treatment Outcome

2009
How dosing of ziprasidone in a state hospital system differs from product labeling.
    The Journal of clinical psychiatry, 2009, Volume: 70, Issue:7

    Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Utilization; Female; Hospitalization; Hospitals, Psychiatric; Hospitals, State; Humans; Male; Piperazines; Prescription Drugs; Product Labeling; Psychotic Disorders; Quetiapine Fumarate; Schizophrenia; Thiazoles; Treatment Outcome

2009
Tardive dyskinesia in a patient treated with quetiapine.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2009, Volume: 10, Issue:1

    Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Basal Ganglia Diseases; Dibenzothiazepines; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Sulpiride; Thiazoles

2009
Activation induced by high-dose ziprasidone: a case report.
    The Journal of clinical psychiatry, 2009, Volume: 70, Issue:9

    Topics: Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Thiazoles

2009
Symptomatic bradycardia with oral aripiprazole and oral ziprasidone.
    The Annals of pharmacotherapy, 2010, Volume: 44, Issue:4

    Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Bradycardia; Delusions; Electrocardiography; Female; Humans; Lithium Carbonate; Piperazines; Psychotic Disorders; Quinolones; Thiazoles

2010
How sequential studies inform drug development: evaluating the effect of food intake on optimal bioavailability of ziprasidone.
    Journal of psychiatric practice, 2010, Volume: 16, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Biological Availability; Biomedical Research; Bipolar Disorder; Dietary Fats; Dose-Response Relationship, Drug; Drug Evaluation; Drug Monitoring; Drugs, Investigational; Energy Intake; Fasting; Female; Food-Drug Interactions; Humans; Intestinal Absorption; Male; Middle Aged; Piperazines; Postprandial Period; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome; Young Adult

2010
Action of aminothiazol on the development of manic access.
    Annales medico-psychologiques, 1946, Volume: 104

    Topics: Bipolar Disorder; Conversion Disorder; Hysteria; Mental Disorders; Neurosyphilis; Psychotic Disorders; Thiazoles

1946
Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia.
    Schizophrenia bulletin, 2012, Volume: 38, Issue:4

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Child; Dibenzothiazepines; Female; Hospitalization; Hospitals, Psychiatric; Humans; Male; Medication Adherence; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Schizophrenia; Thiazoles; Treatment Outcome

2012
Weight gain--as possible predictor of metabolic syndrome.
    Psychiatria Danubina, 2011, Volume: 23, Issue:1

    Topics: Adult; Antipsychotic Agents; Body Mass Index; Dibenzothiazepines; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Metabolic Syndrome; Patient Admission; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Thiazoles; Weight Gain

2011
Ziprasidone induced symptomatic bradycardia: a case report.
    The Australian and New Zealand journal of psychiatry, 2011, Volume: 45, Issue:9

    Topics: Adult; Antipsychotic Agents; Bradycardia; Humans; Male; Piperazines; Psychotic Disorders; Thiazoles

2011
Biological perspectives: update on newer antipsychotic drugs: are they evidence based?
    Perspectives in psychiatric care, 2011, Volume: 47, Issue:4

    Topics: Antipsychotic Agents; Cyclooxygenase 2 Inhibitors; Dibenzocycloheptenes; Evidence-Based Medicine; Heterocyclic Compounds, 4 or More Rings; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Isoindoles; Isoxazoles; Lactones; Lurasidone Hydrochloride; Piperidines; Psychotic Disorders; Pyridines; Serotonin Receptor Agonists; Sulfones; Thiazoles

2011
Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses.
    Neuro endocrinology letters, 2011, Volume: 32, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Medical Records; Olanzapine; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Sulpiride; Thiazoles; Time Factors; Treatment Outcome

2011
A case of recurrent psychosis during sickle cell disease crisis treated successfully with ziprasidone.
    Clinical schizophrenia & related psychoses, 2013, Volume: 6, Issue:4

    Topics: Adult; Analgesics, Opioid; Anemia, Sickle Cell; Antipsychotic Agents; Blood Transfusion; Diagnosis, Differential; Fluid Therapy; Hospitalization; Humans; Male; Pain; Pain Management; Piperazines; Psychotic Disorders; Recurrence; Thiazoles

2013
Ziprasidone and migraine headache.
    The American journal of psychiatry, 2002, Volume: 159, Issue:8

    Topics: Adult; Antipsychotic Agents; Drug Interactions; Female; Humans; Migraine Disorders; Photophobia; Piperazines; Psychotic Disorders; Pyrantel Pamoate; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Thiazoles; Trismus

2002
Rhabdomyolysis, pancreatitis, and hyperglycemia with ziprasidone.
    The American journal of psychiatry, 2002, Volume: 159, Issue:8

    Topics: Antipsychotic Agents; Diabetes Mellitus, Type 2; Diagnosis, Differential; Female; Fever; Humans; Hyperglycemia; Middle Aged; Muscle Rigidity; Neuroleptic Malignant Syndrome; Pancreatitis; Piperazines; Psychotic Disorders; Rhabdomyolysis; Thiazoles

2002
A case of ziprasidone-induced mania and the role of 5-HT2A in mood changes induced by atypical antipsychotics.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:12

    Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Humans; Male; Piperazines; Psychotic Disorders; Serotonin; Thiazoles

2002
Psychic akathisia.
    Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:2

    Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Humans; Piperazines; Psychotic Disorders; Thiazoles

2003
The S. C. T. Z. in the treatment of delirium tremens.
    Therapie, 1959, Volume: 14, Issue:3

    Topics: Humans; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders; Thiazoles

1959
[Intravascular hemolysis and methemoglobinuria complicating the treatment of delirium tremens].
    Svenska lakartidningen, 1961, Apr-21, Volume: 58

    Topics: Alcohol Withdrawal Delirium; Hematologic Diseases; Hemolysis; Humans; Hypnotics and Sedatives; Methemoglobinemia; Psychoses, Alcoholic; Psychotic Disorders; Thiazoles

1961
[Therapeutic trial with SCTZ--a new hypnotic--in delirium tremens and allied conditions].
    Nordisk medicin, 1959, Aug-06, Volume: 62

    Topics: Alcohol Withdrawal Delirium; Anesthesia; Humans; Hypnotics and Sedatives; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders; Thiazoles

1959
[Clinical aspects of Heminevrin].
    Nordisk psykiatrisk tidsskrift. Nordic journal of psychiatry, 1963, Volume: 17

    Topics: Anticonvulsants; Chlormethiazole; Humans; Hypnotics and Sedatives; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders; Thiazoles

1963
[TREATMENT OF DELIRIUM TREMENS WITH CHLORMETHIAZOLE].
    Deutsche medizinische Wochenschrift (1946), 1964, Aug-28, Volume: 89

    Topics: Alcohol Withdrawal Delirium; Chlormethiazole; Humans; Hypnotics and Sedatives; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders; Thiazoles

1964
[THE TREATMENT OF DELIRIUM TREMENS WITH DISTRANEURIN].
    Medizinische Klinik, 1964, Sep-18, Volume: 59

    Topics: Alcohol Withdrawal Delirium; Chlormethiazole; Drug Therapy; Humans; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders; Thiamine; Thiazoles

1964
[Therapeutic trial with SCTZ--a new hypnotic--in psychotic diseases].
    Nordisk medicin, 1959, Aug-06, Volume: 62

    Topics: Electroconvulsive Therapy; Hypnotics and Sedatives; Psychosurgery; Psychotherapy; Psychotic Disorders; Thiazoles

1959
Hypomanic episodes after receiving ziprasidone: an unintended "on-off-on" course of treatment.
    The Journal of clinical psychiatry, 2004, Volume: 65, Issue:1

    Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Drug Administration Schedule; Humans; Male; Piperazines; Psychotic Disorders; Thiazoles

2004
QTc prolongation in multiple drug overdose.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:3

    Topics: Adult; Bupropion; Drug Overdose; Fluoxetine; Humans; Long QT Syndrome; Male; Piperazines; Psychotic Disorders; Thiazoles; Valproic Acid

2004
Ziprasidone treatment of two adolescents with psychosis.
    Journal of child and adolescent psychopharmacology, 2004,Spring, Volume: 14, Issue:1

    Topics: Adolescent; Female; Humans; Male; Piperazines; Psychotic Disorders; Thiazoles

2004
Antipsychotic treatment of psychosis associated with multiple sclerosis.
    Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:4

    Topics: Antipsychotic Agents; Female; Humans; Middle Aged; Multiple Sclerosis; Piperazines; Psychotic Disorders; Schizophrenic Psychology; Thiazoles

2004
Ziprasidone-induced lupus erythematosus.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2004, Volume: 49, Issue:6

    Topics: Depressive Disorder, Major; Female; Humans; Lupus Erythematosus, Systemic; Middle Aged; Piperazines; Psychotic Disorders; Serotonin Antagonists; Thiazoles

2004
Neuroleptic malignant syndrome associated with ziprasidone in an adolescent.
    Clinical therapeutics, 2004, Volume: 26, Issue:7

    Topics: Adolescent; Antipsychotic Agents; Humans; Male; Neuroleptic Malignant Syndrome; Piperazines; Psychotic Disorders; Thiazoles

2004
Intramuscular ziprasidone in youth: a retrospective chart review.
    Journal of child and adolescent psychopharmacology, 2004,Winter, Volume: 14, Issue:4

    Topics: Adolescent; Aggression; Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Female; Humans; Injections, Intramuscular; Male; Piperazines; Psychomotor Agitation; Psychotic Disorders; Retrospective Studies; Thiazoles; Treatment Outcome

2004
Ziprasidone for agitation or psychosis in dementia: four cases.
    International journal of psychiatry in medicine, 2005, Volume: 35, Issue:1

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Dementia; Diagnostic and Statistical Manual of Mental Disorders; Electrocardiography; Female; Humans; Male; Middle Aged; Piperazines; Psychomotor Agitation; Psychotic Disorders; Retrospective Studies; Thiazoles

2005
Ziprasidone in the treatment of Parkinson's disease psychosis.
    European psychiatry : the journal of the Association of European Psychiatrists, 2006, Volume: 21, Issue:8

    Topics: Antipsychotic Agents; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease; Piperazines; Psychotic Disorders; Taiwan; Thiazoles; Treatment Outcome

2006
Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
    International psychogeriatrics, 2005, Volume: 17, Issue:4

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Cerebrovascular Disorders; Cohort Studies; Dementia; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Haloperidol; Hospitalization; Humans; Male; Middle Aged; Olanzapine; Patient Admission; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risk Factors; Risperidone; Thiazoles

2005
Ziprasidone-induced tardive dyskinesia.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2005, Volume: 50, Issue:9

    Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Female; Humans; Piperazines; Psychotic Disorders; Thiazoles

2005
Atypical antipsychotics: special formulations for acute agitation.
    Journal of psychosocial nursing and mental health services, 2005, Volume: 43, Issue:10

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Humans; Olanzapine; Piperazines; Psychomotor Agitation; Psychotic Disorders; Quinolones; Risperidone; Thiazoles

2005
Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    The Annals of pharmacotherapy, 2006, Volume: 40, Issue:1

    Topics: Antipsychotic Agents; Humans; Hypotension; Lithium; Male; Middle Aged; Neuroleptic Malignant Syndrome; Piperazines; Psychotic Disorders; Thiazoles

2006
Ziprasidone-induced priapism requiring surgical treatment.
    European psychiatry : the journal of the Association of European Psychiatrists, 2006, Volume: 21, Issue:1

    Topics: Adult; Bipolar Disorder; Erectile Dysfunction; Humans; Male; Piperazines; Priapism; Psychotic Disorders; Thiazoles

2006
From clinical research to clinical practice: a 4-year review of ziprasidone.
    CNS spectrums, 2005, Volume: 10, Issue:11 Suppl 1

    Topics: Antipsychotic Agents; Controlled Clinical Trials as Topic; Dopamine Antagonists; Humans; Mood Disorders; Piperazines; Psychotic Disorders; Schizophrenia; Serotonin Antagonists; Thiazoles; Treatment Outcome

2005
Real-life switching strategies with second-generation antipsychotics.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:1

    Topics: Antipsychotic Agents; Benzodiazepines; Cohort Studies; Dibenzothiazepines; Drug Administration Schedule; Drug Resistance; Humans; Mental Disorders; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Selection Bias; Thiazoles; Treatment Outcome

2006
Electrocardiographic changes with ziprasidone.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2006, Volume: 45, Issue:6

    Topics: Adolescent; Antipsychotic Agents; Child; Data Interpretation, Statistical; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Psychotic Disorders; Research Design; Selection Bias; Thiazoles; Tourette Syndrome

2006
Injectable atypical antipsychotics for agitation in borderline personality disorder.
    Pharmacopsychiatry, 2006, Volume: 39, Issue:3

    Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Borderline Personality Disorder; Comorbidity; Emergency Services, Psychiatric; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Olanzapine; Piperazines; Psychiatric Status Rating Scales; Psychomotor Agitation; Psychotic Disorders; Schizophrenia; Thiazoles; Treatment Outcome

2006
Effectiveness, tolerability, and safety of ziprasidone in patients with schizophrenia or schizoaffective disorder: results of a multi-centre observational trial.
    European psychiatry : the journal of the Association of European Psychiatrists, 2007, Volume: 22, Issue:3

    Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Austria; Blood Glucose; Body Weight; Brief Psychiatric Rating Scale; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Germany; Humans; Lipids; Male; Middle Aged; Patient Dropouts; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Psychotic Disorders; Quality of Life; Schizophrenia; Thiazoles; Treatment Outcome

2007
Datapoints: The ups and downs of dosing second-generation antipsychotics.
    Psychiatric services (Washington, D.C.), 2007, Volume: 58, Issue:1

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Dibenzothiazepines; Dose-Response Relationship, Drug; Humans; Olanzapine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Thiazoles

2007
Acute pisa syndrome and pharnygolaryngeal dystonia due to ziprasidone.
    The Journal of neuropsychiatry and clinical neurosciences, 2008,Winter, Volume: 20, Issue:1

    Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dystonia; Humans; Male; Pharyngeal Diseases; Piperazines; Psychotic Disorders; Thiazoles

2008
Urinary retention associated with ziprasidone: a case report.
    The Journal of clinical psychiatry, 2008, Volume: 69, Issue:3

    Topics: Antipsychotic Agents; Diagnostic and Statistical Manual of Mental Disorders; Efferent Pathways; Female; Humans; Middle Aged; Muscle Contraction; Muscle, Smooth; Piperazines; Psychotic Disorders; Raphe Nuclei; Thiazoles; Urinary Bladder; Urinary Retention

2008
Did CATIE influence antipsychotic use?
    Psychiatric services (Washington, D.C.), 2008, Volume: 59, Issue:5

    Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dibenzothiazepines; Drug Therapy; Haloperidol; Humans; Olanzapine; Perphenazine; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Risperidone; Schizophrenia; Thiazoles

2008
Sustaining short-term gains for future progress.
    International clinical psychopharmacology, 2001, Volume: 16 Suppl 1

    Topics: Acute Disease; Administration, Oral; Antipsychotic Agents; Humans; Injections, Intramuscular; Piperazines; Psychotic Disorders; Thiazoles

2001
Experience with ziprasidone.
    Journal of the American Academy of Child and Adolescent Psychiatry, 2002, Volume: 41, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Contraindications; Depressive Disorder, Major; Drug Evaluation; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Psychotic Disorders; Thiazoles

2002
Experience with chlormethiazole in agitated conditions.
    Acta psychiatrica Scandinavica. Supplementum, 1966, Volume: 192

    Topics: Alcohol Amnestic Disorder; Anxiety; Chlordiazepoxide; Chlormethiazole; Epilepsy; Female; Humans; Hypnotics and Sedatives; Male; Psychotic Disorders; Thiazoles; Tranquilizing Agents

1966